As published in the journal Food and Chemical Toxicology, the biopharmaceutical drug development firm's sponsored research used co-cultured human, primary immune cells as a model to evaluate the ability of selected Cannabis constituents to decrease inflammation.

This is the third U.S. patent awarded to GBS's disease-specific Cannabinoid-Containing Complex Mixtures (CCCM™), which further validates GB Sciences' drug discovery platform and strengthens its intellectual property patent portfolio

Based on data from a two-year study, GBS's CCCM were designed for the treatment of Cytokine Storm Syndromes, while preserving anti-viral immune reactions

A recent survey by a dental insurance company indicated that dentists prefer their patients eat chocolate over all other types of candy. Why does the popularity of this confection in the public eye match with its acceptance by many dentists?

Products from the neem tree are traditionally used in its indigenous country of India for oral hygiene. Now its observed anti-inflammatory properties are being touted for pain treatment, including that caused by TMJ syndrome. What is indicated by the scientific literature and have any reputable human studies been performed?

The implication of a powerful clinical remedy for treatment of Alzheimer's disease is really a great step forward in the clinical world that may aid in alleviating the statistics of 106 million.